These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 36093679)

  • 21. Evolving frequency and outcomes of liver transplantation based on etiology of liver disease.
    Singal AK; Guturu P; Hmoud B; Kuo YF; Salameh H; Wiesner RH
    Transplantation; 2013 Mar; 95(5):755-60. PubMed ID: 23370710
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liver transplantation for hepatitis B virus: Decreasing indication and changing trends.
    Al-Hamoudi W; Elsiesy H; Bendahmash A; Al-Masri N; Ali S; Allam N; Al Sofayan M; Al Bahili H; Al Sebayel M; Broering D; Saab S; Abaalkhail F
    World J Gastroenterol; 2015 Jul; 21(26):8140-7. PubMed ID: 26185387
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survival after liver transplantation for hepatocellular carcinoma in the model for end-stage liver disease and pre-model for end-stage liver disease eras and the independent impact of hepatitis C virus.
    Thuluvath PJ; Maheshwari A; Thuluvath NP; Nguyen GC; Segev DL
    Liver Transpl; 2009 Jul; 15(7):754-62. PubMed ID: 19562709
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis C infection and hepatocellular carcinoma in liver transplantation: a 20-year experience.
    Dumitra S; Alabbad SI; Barkun JS; Dumitra TC; Coutsinos D; Metrakos PP; Hassanain M; Paraskevas S; Chaudhury P; Tchervenkov JI
    HPB (Oxford); 2013 Sep; 15(9):724-31. PubMed ID: 23490176
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alcohol Relapse After Liver Transplantation for Alcoholic Cirrhosis-Impact on Liver Graft and Patient Survival: A Meta-analysis.
    Kodali S; Kaif M; Tariq R; Singal AK
    Alcohol Alcohol; 2018 Mar; 53(2):166-172. PubMed ID: 29194512
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liver Transplantation in Patients with Alcoholic Liver Disease: A Retrospective Study.
    Vassallo GA; Tarli C; Rando MM; Mosoni C; Mirijello A; Agyei-Nkansah A; Antonelli M; Sestito L; Perotti G; Di Giuda D; Agnes S; Grieco A; Gasbarrini A; Addolorato G;
    Alcohol Alcohol; 2018 Mar; 53(2):151-156. PubMed ID: 29206894
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liver Transplantation in Cryptogenic Cirrhosis: Outcome Comparisons Between NASH, Alcoholic, and AIH Cirrhosis.
    Thuluvath PJ; Hanish S; Savva Y
    Transplantation; 2018 Apr; 102(4):656-663. PubMed ID: 29215462
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list.
    Vitale A; Volk ML; De Feo TM; Burra P; Frigo AC; Ramirez Morales R; De Carlis L; Belli L; Colledan M; Fagiuoli S; Rossi G; Andorno E; Baccarani U; Regalia E; Vivarelli M; Donataccio M; Cillo U;
    J Hepatol; 2014 Feb; 60(2):290-7. PubMed ID: 24161408
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Negative impact of de novo malignancies rather than alcohol relapse on survival after liver transplantation for alcoholic cirrhosis: a retrospective analysis of 305 patients in a single center.
    Dumortier J; Guillaud O; Adham M; Boucaud C; Delafosse B; Bouffard Y; Paliard P; Scoazec JY; Boillot O
    Am J Gastroenterol; 2007 May; 102(5):1032-41. PubMed ID: 17313502
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk factors for alcohol relapse after liver transplantation for alcoholic cirrhosis in Japan.
    Egawa H; Nishimura K; Teramukai S; Yamamoto M; Umeshita K; Furukawa H; Uemoto S
    Liver Transpl; 2014 Mar; 20(3):298-310. PubMed ID: 24470014
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: a reasonable strategy?
    Adam R; Azoulay D; Castaing D; Eshkenazy R; Pascal G; Hashizume K; Samuel D; Bismuth H
    Ann Surg; 2003 Oct; 238(4):508-18; discussion 518-9. PubMed ID: 14530722
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Direct-acting antivirals do not increase the risk of hepatocellular carcinoma recurrence after local-regional therapy or liver transplant waitlist dropout.
    Huang AC; Mehta N; Dodge JL; Yao FY; Terrault NA
    Hepatology; 2018 Aug; 68(2):449-461. PubMed ID: 29476694
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis C virus related cirrhosis decreased as indication to liver transplantation since the introduction of direct-acting antivirals: A single-center study.
    Ferrarese A; Germani G; Gambato M; Russo FP; Senzolo M; Zanetto A; Shalaby S; Cillo U; Zanus G; Angeli P; Burra P
    World J Gastroenterol; 2018 Oct; 24(38):4403-4411. PubMed ID: 30344424
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Donation After Circulatory Death Is Associated With Similar Posttransplant Survival in All but the Highest-Risk Hepatocellular Carcinoma Patients.
    Silverstein J; Roll G; Dodge JL; Grab JD; Yao FY; Mehta N
    Liver Transpl; 2020 Sep; 26(9):1100-1111. PubMed ID: 32531867
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diabetes is not associated with an increased risk of hepatocellular carcinoma in patients with alcoholic or hepatitis C virus cirrhosis.
    Rodríguez-Escaja C; Á Navascués C; González-Diéguez L; Cadahía V; Varela M; de Jorge MÁ; Castaño-García A; Rodríguez M
    Rev Esp Enferm Dig; 2021 Jul; 113(7):505-511. PubMed ID: 33244982
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Meta-analysis of patient survival and rate of alcohol relapse in liver-transplanted patients for acute alcoholic hepatitis.
    Al-Saeedi M; Barout MH; Probst P; Khajeh E; Weiss KH; Diener MK; Mehrabi A
    Langenbecks Arch Surg; 2018 Nov; 403(7):825-836. PubMed ID: 30349998
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human immunodeficiency virus infection does not worsen prognosis of liver transplantation for hepatocellular carcinoma.
    Agüero F; Forner A; Manzardo C; Valdivieso A; Blanes M; Barcena R; Rafecas A; Castells L; Abradelo M; Torre-Cisneros J; Gonzalez-Dieguez L; Salcedo M; Serrano T; Jimenez-Perez M; Herrero JI; Gastaca M; Aguilera V; Fabregat J; Del Campo S; Bilbao I; Romero CJ; Moreno A; Rimola A; Miro JM;
    Hepatology; 2016 Feb; 63(2):488-98. PubMed ID: 26516761
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bone mineral density predicts posttransplant survival among hepatocellular carcinoma liver transplant recipients.
    Sharma P; Parikh ND; Yu J; Barman P; Derstine BA; Sonnenday CJ; Wang SC; Su GL
    Liver Transpl; 2016 Aug; 22(8):1092-8. PubMed ID: 27064263
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effectiveness of Direct-acting Agents After Liver Transplantation A Real-life Study in Rio de Janeiro.
    Pinto L; Balbi E; Halpern M; Carius L; Roma J; Cardoso SW; Grinsztejn B; Veloso VG; Pacheco L; Perazzo H
    Arch Med Res; 2022 Sep; 53(6):585-593. PubMed ID: 36114037
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between HCV and HBV infection in hepatocellular carcinoma and alcoholic liver disease.
    Nalpas B; Driss F; Pol S; Hamelin B; Housset C; Brechot C; Berthelot P
    J Hepatol; 1991 Jan; 12(1):70-4. PubMed ID: 1848875
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.